Invesaro

Stocks CTRI Financial statements

Financial statements

Centuri Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Centuri Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2022FY2024FY2024FY2025
Revenue2,7602,8992,6372,983
Cost of revenue2,5462,6262,4172,736
Gross profit215273221247
Selling, general and administrative109110107126
Operating income-101-77.686.892.8
Other non-operating income-0.890.060.380.19
Pre-tax income-164-175-3.3614.6
Income tax1.39.533.47-8.06
Net income-168-186-6.7222.4
EBITDA24.241.2195204
EPS, basic-2.35-2.60-0.080.25
EPS, diluted-2.35-2.60-0.080.25
Shares, basic (weighted)71.771.783.390
Shares, diluted (weighted)71.771.783.390.3
Dividend per share15,000.00

Balance sheet

FY2022FY2024FY2024FY2025
Cash and equivalents6433.449127
Receivables347281315
Other current assets32.332.845
Total current assets683601881
Property, plant and equipment545511467
Lease right-of-use assets118104176
Goodwill588376368396
Intangible assets369341343
Other non-current assets54.6115120
Total assets2,1902,0742,408
Accounts payable117126194
Accrued liabilities187174185
Deferred revenue35.843.72550.5
Short-term debt42.63029.5
Total current liabilities421382496
Long-term debt1,108844708
Lease liabilities10591.7154
Other non-current liabilities71.166.183.8
Total liabilities1,8651,5141,529
Total debt1,151874738
Paid-in capital3747191,008
Retained earnings-144-151-128
Other comprehensive income-4.03-13.2-7.37
Shareholders' equity387226556873
Total equity387226556873
Total liabilities and equity2,1902,0742,408
Shares outstanding088.5101

Cash flow statement

FY2022FY2024FY2024FY2025
Net income-165-185-6.8222.7
Depreciation and amortization126119109112
Stock-based compensation1.651.852.238.08
Deferred income tax-7.45-9.67-19.2-14.6
Change in payables49.5-26.87.5760.9
Cash from operations94.616715878.1
Capital expenditures-130-107-99.3-86.3
Acquisitions00-45.8
Cash from investing-117-94.9-89.4-88.2
Dividends paid-1500
Cash from financing-27.5-103-52.688.8
Exchange rate effect-0.850.27-0.620.37
Net change in cash-50.7-30.615.679
Free cash flow-3560.858.9-8.2
Interest paid50.298.378.367
Income taxes paid3.4813.69.363.58

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $20.51 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin7.8%Gross profit / revenue.
Operating margin2.7%Operating income / revenue.
EBITDA margin6.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin0.8%Pre-tax income / revenue.
Net margin0.9%Net income / revenue.
FCF margin-0.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.2%Cash from operations / revenue.
Effective tax rate-10.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)3.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.2%Net income / average total assets.
Return on invested capital (ROIC)4.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue4.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.6%Capital expenditures / revenue.
D&A / revenue3.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y13.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y2.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y11.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y7.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y4.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y103.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-50.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-6.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y-113.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y57.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y31.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y16.1%Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y8.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y8.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.82xCurrent assets / current liabilities.
Quick ratio0.88x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.08x(Cash + short-term investments) / current liabilities.
Debt / equity0.83xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets29.9%Total debt / total assets.
Liabilities / assets63.6%Total liabilities / total assets.
Net debt$677.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.32xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$399.9MCurrent assets - current liabilities.
Goodwill and intangibles / assets29.9%(Goodwill + intangible assets) / total assets.
Tangible book value$149.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.41xRevenue / average total assets.
Fixed asset turnover7.29xRevenue / average property, plant and equipment.
Receivables turnover8.66xRevenue / average receivables.
Days sales outstanding42 days365 x average receivables / revenue.
Days payables19 days365 x average accounts payable / cost of revenue.
FCF conversion-52.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow120.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.28Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$33.44Revenue / diluted weighted shares.
FCF per share-$0.15Free cash flow / diluted weighted shares.
Operating cash flow per share$0.73Cash from operations / diluted weighted shares.
Book value per share$8.61Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.48Tangible book value / shares outstanding.
Cash per share$0.40(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$2.07BShare price x shares outstanding.
Enterprise value$2.75BMarket cap + total debt - cash - short-term investments.
P/E71.8xMarket cap / net income. Only when net income is positive.
P/S0.61xMarket cap / revenue.
P/B2.38xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book13.9xMarket cap / tangible book value, when positive.
P/OCF27.9xMarket cap / cash from operations, when positive.
EV/Sales0.81xEnterprise value / revenue.
EV/EBIT29.6xEnterprise value / operating income, when both are positive.
EV/EBITDA13.5xEnterprise value / EBITDA, when both are positive.
FCF yield-0.7%Free cash flow / market cap.
Earnings yield1.4%Net income / market cap (the inverse of P/E).
What was Centuri Holdings, Inc.'s revenue in fiscal 2025?

Centuri Holdings, Inc. reported revenue of $2.98B for fiscal 2025, 13.1% higher than the year before.

Was Centuri Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $22.4M, a net margin of 0.8%.

How much free cash flow did Centuri Holdings, Inc. generate in fiscal 2025?

Cash from operations of $78.1M minus capital expenditures of $86.3M left free cash flow of -$8.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Centuri Holdings, Inc.